Newsroom Stories

Fewer than half of people worldwide who have already had one heart attack or stroke take daily aspirin to prevent a second one, according to a new study led by researchers at the School of Medicine. Increasing daily aspirin use in such patients could reduce cardiovascular deaths.

For people who have contracted the COVID-19 virus, pain and suffering may continue two years after infection, according to a new study from the School of Medicine and the Veterans Affairs St. Louis Health Care system.

Raven Maragh-Lloyd, an assistant professor of African and African American studies in Arts & Sciences, will serve as co-principal investigator for a $1.7 million grant investigating online influence campaigns.

The Class of 2027 moves onto the South 40 Friday and Saturday, Aug. 18 and 19. The class is the most diverse in university history. The students hail from 50 states and 29 countries; 53% identify as students of color and 21% are Pell Grant-eligible.

In this highly polarized, post-lockdown world, the college transition can seem especially difficult. WashU happiness expert Tim Bono explains how students can set themselves up for success.

A new test for two blood cancers — developed by a team at the School of Medicine — is the first whole-genome sequencing test for cancer to be approved for reimbursement by the Centers for Medicare & Medicaid Services.

A study from biologist Elizabeth Mallott in Arts & Sciences highlights a critical development window during which racial differences in the gut microbiome emerge. Early social and environmental exposures can have large and lasting effects on child development and adult health.

The Food and Drug Administration has granted full approval to Leqembi for patients in the early stages of Alzheimer’s disease. The School of Medicine’s Barbara Joy Snider, MD, PhD, answers questions about the drug.

Led by the School of Medicine and other institutions around the world, the Clinical Proteomic Tumor Analysis Consortium has completed a deep analysis of the proteins driving cancer across multiple tumor types. The findings could help lead to new therapies.

The university’s Social Policy Institute has received a $1.6 million grant from JPMorgan Chase to help the institute’s Workforce Economic Inclusion and Mobility Project address low-wage frontline and essential workers’ employment vulnerability.